thiazoles has been researched along with azd8186 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, ST; Baselga, J; Carver, BS; Chandarlapaty, S; de Stanchina, E; Hancox, U; Rodrik-Outmezguine, V; Rosen, N; Sawyers, CL; Scher, HI; Schwartz, S; Trigwell, CB; Will, M; Wongvipat, J; Yellen, P | 1 |
| Cescon, DW; Gorrini, C; Mak, TW | 1 |
2 other study(ies) available for thiazoles and azd8186
| Article | Year |
|---|---|
Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ.
Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Chromones; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Transplantation; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Signal Transduction; Thiazoles | 2015 |
Breaking up is hard to do: PI3K isoforms on the rebound.
Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromones; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Neoplasms; ortho-Aminobenzoates; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Pyrimidinones; Thiazoles | 2015 |